Navigation Links
Memory Loss Linked to Cognitive Disorders

A new study has developed the first images of the physical changes in brain cells thought to underlie memory thus linking memory loss to cognitive disorders.

Earlier studies have established that a physiological effect known as long-term potentiation (LTP) encodes everyday forms of memory.

In neuroscience, LTP is an increase in the strength of a chemical synapse that lasts from minutes to several days. It is widely considered one of the major mechanisms by which memories are formed and stored in the brain.

The study was conducted by a team of researchers led by Christine M. Gall and Gary Lynch at the University of California, Irvine.

As part of the study, researchers collected brain tissues from rats and mice, which was kept alive in specially constructed equipment and induced LTP by stimulating synapses with a rhythm known to be critical to memory formation.

The brain slices were then sectioned and stained with one antibody that attaches to activated proteins involved with LTP and a second one that labels synapses. Newly developed microscopic methods were used to visualize and measure synapses that had both antibodies attached.

Researchers found with the images that the size and shape of synapses were changed by LTP.

It was shown how LTP deficiencies accompany the memory loss seen during the early stages of Huntingtons disease, an incurable neurodegenerative disease characterized by disturbances to memory and learning.

The way is now open to mapping where in the brain memories are laid down. Seeing memory-related physical changes to synapses means that we can at last use mouse models to test if the effects of retardation, aging and various cognitive disorders involve a specific, long-suspected defect in the connections between cortical neurons, Lynch said.

Scientists also found that LTP structures encoding memory were defective in mouse mod els of Huntingtons disease. They discovered that these synaptic defects could be fully reversed through treatment with a brain growth factor released at synapses.

Ampakines, a new class of drugs developed by researchers that is currently in clinical development for Alzheimers disease and ADHD, increase the levels of this growth factor and potentially emerge as a therapy for the cognitive problems associated with Huntingtons.

The findings of the study were published in the May issue of the Journal of Neuroscience.


'"/>




Related medicine news :

1. Memory problem? solve a crossword
2. Deep Sleep Doesnt Increase Memory
3. For a Better Memory
4. Memory loss associated with microbes
5. Memory loss always goes hand with Depression
6. Memory deprivation after operations
7. Sage Improves Memory
8. Memory said to automatically improve with age
9. Enzyme Associated with Memory
10. Enzyme Associated With Memory
11. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... Drs. Justin Kolnick, Kara Diamond, ... teaching their patients about the key role this treatment plays in protecting oral health, ... endodontist. To better serve those who need a root canal in White Plains, NY ...
(Date:3/27/2017)... ... March 27, 2017 , ... SyncDog, Inc. , the ... partners LG Business Solutions at ATARC Federal Mobile Computing Summit , March ... provide education and examination into the mobility tools and technology employed by the ...
(Date:3/27/2017)... ... ... The Case Management Society of America (CMSA) will install six new members ... has elected their upcoming President-Elect, Secretary, Treasurer and two Directors to serve on the ... position has also been added to the BOD, per an appointment made by CMSA ...
(Date:3/27/2017)... ... March 27, 2017 , ... Advantexe ... announced the launch of a new research study, The Business Readiness Report. The ... execute that strategy, and the actual success of achieving individual and company goals. ...
(Date:3/27/2017)... ... ... is still in shock after receiving a $2,500 Academic Award from California Casualty . ... , She thinks the coming week is going to be a very joyful for her ... my students.” , The award will allow the 4th grade teacher at Tumwater Hill Elementary ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017  Twist Bioscience, a company accelerating science ... that it raised an additional $33 million. To date, ... "It is an exciting time to ... and continue to deliver industry-leading gene volume to our ... Emily M. Leproust, Ph.D., CEO of Twist Bioscience. "We ...
(Date:3/27/2017)... , March 27, 2017  PhaseRx, Inc. (NASDAQ: ... life-threatening inherited liver diseases in children, today reported ... year ended December 31, 2016 and provided an ... "PhaseRx continued to make progress during the fourth ... results from our non-human primate safety study, and with ...
(Date:3/27/2017)... , March 27, 2017 Invivotek, LLC, a ... in vivo pharmacology contract research organization (CRO), ... to its newly expanded preclinical research facility in ... provides a cleaner, renewable energy source to reduce costs ... Completion of the Genesis Solar Farm follows Invivotek,s recent ...
Breaking Medicine Technology: